Your browser doesn't support javascript.
loading
Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy.
Zhang, Yin; Sun, Meili; Huang, Guichun; Yin, Linlin; Lai, Qinghua; Yang, Yunlong; Xing, Xiaoming; Yu, Guohua; Sun, Yuping; Wang, Xinsheng; Nie, Guohui; Liu, Yizhi; Cao, Yihai.
Afiliación
  • Zhang Y; Central Research Laboratory, The Affiliated Hospital of Qingdao University, Qingdao 266071, China.
  • Sun M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77 Stockholm, Sweden.
  • Huang G; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060, China.
  • Yin L; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77 Stockholm, Sweden.
  • Lai Q; Department of Oncology, Jinan Central Hospital, Shandong University, Jinan, Shandong 250013, China.
  • Yang Y; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77 Stockholm, Sweden.
  • Xing X; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77 Stockholm, Sweden.
  • Yu G; Department of Hematology and Oncology, The Fourth Hospital of Jinan, Jinan, Shandong 250031, China.
  • Sun Y; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77 Stockholm, Sweden.
  • Wang X; Department of Oncology, Jinan Central Hospital, Shandong University, Jinan, Shandong 250013, China.
  • Nie G; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77 Stockholm, Sweden.
  • Liu Y; Key Laboratory of International Collaborations, Second People's Hospital of Shenzhen, First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China.
  • Cao Y; Central Research Laboratory, The Affiliated Hospital of Qingdao University, Qingdao 266071, China.
Proc Natl Acad Sci U S A ; 114(26): E5226-E5235, 2017 06 27.
Article en En | MEDLINE | ID: mdl-28607065

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Capecitabina / Neoplasias Experimentales / Neovascularización Patológica Límite: Animals / Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2017 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Capecitabina / Neoplasias Experimentales / Neovascularización Patológica Límite: Animals / Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2017 Tipo del documento: Article País de afiliación: China